Literature DB >> 21871103

Product Development Partnerships: Case studies of a new mechanism for health technology innovation.

Richard T Mahoney1.   

Abstract

There is a continuing need for new health technologies to address the disease burdens of developing countries. In the last decade Product Development Partnerships (PDP) have emerged that are making important contributions to the development of these technologies. PDPs are a form of public private partnerships that focus on health technology development. PDPs reflect the current phase in the history of health technology development: the Era of Partnerships, in which the public and private sectors have found productive ways to collaborate. Successful innovation depends on addressing six determinants of innovation. We examine four case studies of PDPs and show how they have addressed the six determinants to achieve success.

Entities:  

Year:  2011        PMID: 21871103      PMCID: PMC3175464          DOI: 10.1186/1478-4505-9-33

Source DB:  PubMed          Journal:  Health Res Policy Syst        ISSN: 1478-4505


  17 in total

Review 1.  Global public-private partnerships: Part II--What are the health issues for global governance?

Authors:  K Buse; G Walt
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Forecasting dengue vaccine demand in disease endemic and non-endemic countries.

Authors:  Ananda Amarasinghe; Ole Wichmann; Harold S Margolis; Richard T Mahoney
Journal:  Hum Vaccin       Date:  2010-09-01

3.  The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study.

Authors:  D Sur; J L Deen; B Manna; S K Niyogi; A K Deb; S Kanungo; B L Sarkar; D R Kim; M C Danovaro-Holliday; K Holliday; V K Gupta; M Ali; L von Seidlein; J D Clemens; S K Bhattacharya
Journal:  Arch Dis Child       Date:  2005-06-17       Impact factor: 3.791

4.  The role of emerging manufacturers in access to innovative vaccines of public health importance.

Authors:  Julie B Milstien; Miloud Kaddar
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

5.  "Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation.

Authors:  Robert Edelman; Joachim Hombach
Journal:  Vaccine       Date:  2008-06-11       Impact factor: 3.641

6.  Private demand for cholera vaccines in rural Matlab, Bangladesh.

Authors:  Ziaul Islam; Brian Maskery; Andrew Nyamete; Mark S Horowitz; Mohammad Yunus; Dale Whittington
Journal:  Health Policy       Date:  2007-09-05       Impact factor: 2.980

7.  Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.

Authors:  Dipika Sur; Anna Lena Lopez; Suman Kanungo; Allison Paisley; Byomkesh Manna; Mohammad Ali; Swapan K Niyogi; Jin Kyung Park; Banawarilal Sarkar; Mahesh K Puri; Deok Ryun Kim; Jacqueline L Deen; Jan Holmgren; Rodney Carbis; Raman Rao; Thu Van Nguyen; Allan Donner; Nirmal K Ganguly; G Balakrish Nair; Sujit K Bhattacharya; John D Clemens
Journal:  Lancet       Date:  2009-10-08       Impact factor: 79.321

8.  Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.

Authors:  Salim Abdulla; Issaka Sagara; Steffen Borrmann; Umberto D'Alessandro; Raquel González; Mary Hamel; Bernhards Ogutu; Andreas Mårtensson; John Lyimo; Hamma Maiga; Philip Sasi; Alain Nahum; Quique Bassat; Elizabeth Juma; Lucas Otieno; Anders Björkman; Hans Peter Beck; Kim Andriano; Marc Cousin; Gilbert Lefèvre; David Ubben; Zulfikarali Premji
Journal:  Lancet       Date:  2008-10-14       Impact factor: 79.321

9.  Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.

Authors:  Dinh Thiem Vu; M Moshaddeque Hossain; Dinh Son Nguyen; Thai Hoa Nguyen; Malla R Rao; Gia Canh Do; Abdollah Naficy; Thi Ke Nguyen; Camilo J Acosta; Jacqueline L Deen; John D Clemens; Duc Trach Dang
Journal:  J Health Popul Nutr       Date:  2003-12       Impact factor: 2.000

10.  The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa.

Authors:  Jacqueline L Deen; Lorenz von Seidlein; Dipika Sur; Magdarina Agtini; Marcelino E S Lucas; Anna Lena Lopez; Deok Ryun Kim; Mohammad Ali; John D Clemens
Journal:  PLoS Negl Trop Dis       Date:  2008-02-20
View more
  12 in total

1.  Linking research to global health equity: the contribution of product development partnerships to access to medicines and research capacity building.

Authors:  Bridget Pratt; Bebe Loff
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

2.  Developing sustainable global health technologies: insight from an initiative to address neonatal hypothermia.

Authors:  Rajesh Gupta; Rajan Patel; Naganand Murty; Rahul Panicker; Jane Chen
Journal:  J Public Health Policy       Date:  2014-11-13       Impact factor: 2.222

3.  Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon.

Authors:  Sonali Kochhar
Journal:  Hum Vaccin Immunother       Date:  2013-01-15       Impact factor: 3.452

4.  Responding to maternal, neonatal and child health equipment needs in Kenya: a model for an innovation ecosystem leveraging on collaborations and partnerships.

Authors:  Richard Ayah; John Ong'ech; Edwin Maina Mbugua; Rose Chepchumba Kosgei; Katie Waller; David Gathara
Journal:  BMJ Innov       Date:  2020-04-24

5.  Epidemiology in a changing world: implications for population-based research on mental disorders.

Authors:  B Cooper
Journal:  Epidemiol Psychiatr Sci       Date:  2013-12-17       Impact factor: 6.892

Review 6.  Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development.

Authors:  Nicole Lurie; Gerald T Keusch; Victor J Dzau
Journal:  Lancet       Date:  2021-03-09       Impact factor: 202.731

7.  R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014.

Authors:  Theolis Costa Barbosa Bessa; Erika Santos de Aragão; Jane Mary Medeiros Guimarães; Bethânia de Araújo Almeida
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

8.  Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review.

Authors:  Simone Fanelli; Fiorella Pia Salvatore; Gianluigi De Pascale; Nicola Faccilongo
Journal:  BMC Health Serv Res       Date:  2020-06-22       Impact factor: 2.655

9.  Revisiting the concept of Innovative Developing Countries (IDCs) for its relevance to health innovation and neglected tropical diseases and for the prevention and control of epidemics.

Authors:  Alexandre Guimarães Vasconcellos; Bruna de Paula Fonseca E Fonseca; Carlos Medicis Morel
Journal:  PLoS Negl Trop Dis       Date:  2018-07-12

Review 10.  Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.

Authors:  Prasad S Kulkarni; Muriel Socquet; Suresh S Jadhav; Subhash V Kapre; F Marc LaForce; Cyrus S Poonawalla
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.